A new weight-loss pill called Foundayo has been approved for use in the UK, adding another medicine from Eli Lilly to the country’s weight-management options.
Foundayo is made by Eli Lilly, the pharmaceutical company behind the Mounjaro jab. The approval means the pill has been cleared for use in the UK, although the supplied information does not specify the approving body, prescribing criteria or when patients may begin receiving it.
The development is notable because it concerns a tablet rather than an injection. Mounjaro, also made by Eli Lilly, is administered as a jab, while Foundayo is described as a pill.
No further details were provided on eligibility, cost, availability through the NHS or private providers, or any conditions attached to its use. The latest known position is that Foundayo has received UK approval, with practical rollout information still not set out in the supplied material.
